About
Activity
-
Wow! This case report provides quite an insight into intrahost diversity and evolution and the emergence of variants. The convergent evolution...
Wow! This case report provides quite an insight into intrahost diversity and evolution and the emergence of variants. The convergent evolution...
Liked by Keith Robison
-
This week, we announced BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), the first U.S. multi-state...
This week, we announced BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), the first U.S. multi-state...
Liked by Keith Robison
-
In this study, a first-order transition-probability model over the first ten bases at the 5′ end (FOTP-10) outperforms other #cfDNA #fragmentomic and...
In this study, a first-order transition-probability model over the first ten bases at the 5′ end (FOTP-10) outperforms other #cfDNA #fragmentomic and...
Liked by Keith Robison
Experience & Education
-
Ginkgo Bioworks, Inc.
View Keith’s full experience
See their title, tenure and more.
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Publications
-
The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models
Oncogene
Heat shock protein 90 (Hsp90) is an emerging target for cancer therapy due to its important role in maintaining the activity and stability of key oncogenic signaling proteins. We show here that the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion protein, presumed to be the oncogenic driver in about 5% of patients with non-small cell lung cancer (NSCLC), is associated with Hsp90 in cells and is rapidly degraded upon exposure of cells to IPI-504. We...
Heat shock protein 90 (Hsp90) is an emerging target for cancer therapy due to its important role in maintaining the activity and stability of key oncogenic signaling proteins. We show here that the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion protein, presumed to be the oncogenic driver in about 5% of patients with non-small cell lung cancer (NSCLC), is associated with Hsp90 in cells and is rapidly degraded upon exposure of cells to IPI-504. We find EML4-ALK to be more sensitive to Hsp90 inhibition than either HER2 or mutant epidermal growth factor receptor (EGFR) with an inhibitory concentration (IC)(50) for protein degradation in the low nanomolar range. This degradation leads to a potent inhibition of downstream signaling pathways and to the induction of growth arrest and apoptosis in cells carrying the EML4-ALK fusion. To generate a causative link between the expression of EML4-ALK and sensitivity to IPI-504, we introduced an EML4-ALK cDNA into HEK293 cells and show that the expression of the fusion protein sensitizes cells to IPI-504 both in vitro and in vivo. In a xenograft model of a human NSCLC cell line containing the ALK rearrangement, we observe tumor regression at clinically relevant doses of IPI-504. Finally, cells that have been selected for resistance to ALK kinase inhibitors retain their sensitivity to IPI-504. We have recently observed partial responses to administration of IPI-504 as a single agent in a phase 2 clinical trial in patients with NSCLC, specifically in patients that carry an ALK rearrangement. This study provides a molecular explanation for these clinical observations.
Other authors -
Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations.
-
The structural features determining efficient biosynthesis, stability in the membrane and, after solubilization, in detergents are not well understood for integral membrane proteins such as G protein-coupled receptors (GPCRs). Starting from the rat neurotensin receptor 1, a class A GPCR, we generated a separate library comprising all 64 codons for each amino acid position. By combining a previously developed FACS-based selection system for functional expression [Sarkar C, et al. (2009) Proc...
The structural features determining efficient biosynthesis, stability in the membrane and, after solubilization, in detergents are not well understood for integral membrane proteins such as G protein-coupled receptors (GPCRs). Starting from the rat neurotensin receptor 1, a class A GPCR, we generated a separate library comprising all 64 codons for each amino acid position. By combining a previously developed FACS-based selection system for functional expression [Sarkar C, et al. (2009) Proc Natl Acad Sci USA 105:14808-14813] with ultradeep 454 sequencing, we determined the amino acid preference in every position and identified several positions in the natural sequence that restrict functional expression. A strong accumulation of shifts, i.e., a residue preference different from wild type, is detected for helix 1, suggesting a key role in receptor biosynthesis. Furthermore, under selective pressure we observe a shift of the most conserved residues of the N-terminal helices. This unique data set allows us to compare the in vitro evolution of a GPCR to the natural evolution of the GPCR family and to observe how selective pressure shapes the sequence space covered by functional molecules. Under the applied selective pressure, several positions shift away from the wild-type sequence, and these improve the biophysical properties. We discuss possible structural reasons for conserved and shifted residues.
Other authors
Recommendations received
4 people have recommended Keith
Join now to viewMore activity by Keith
-
Honored that Othram Inc. could assist Saskatoon and Toronto Police Services to Identify Canada's "Woman in the Well". Her name is Alice Burke Spence,...
Honored that Othram Inc. could assist Saskatoon and Toronto Police Services to Identify Canada's "Woman in the Well". Her name is Alice Burke Spence,...
Liked by Keith Robison
-
At ASHG this year, Complete Genomics debuts our DNBSEQ User Group Meeting, announces a CoLab presentation, Industry Workshop, poster sessions, new...
At ASHG this year, Complete Genomics debuts our DNBSEQ User Group Meeting, announces a CoLab presentation, Industry Workshop, poster sessions, new...
Liked by Keith Robison
-
Excited to attend and present our work "Genetic Testing of Breast and Ovarian Cancer Patients in Routine Clinical Practice in Estonia" at...
Excited to attend and present our work "Genetic Testing of Breast and Ovarian Cancer Patients in Routine Clinical Practice in Estonia" at...
Liked by Keith Robison
-
My studio is where every canvas begins its journey. I love to be in the flow of creation and letting go of everything to be in the moment. Here’s a...
My studio is where every canvas begins its journey. I love to be in the flow of creation and letting go of everything to be in the moment. Here’s a...
Liked by Keith Robison
-
We’re excited to share a new multi-year collaboration with Takeda, building on the success of our first engagement. Under the agreement, Nabla will...
We’re excited to share a new multi-year collaboration with Takeda, building on the success of our first engagement. Under the agreement, Nabla will...
Liked by Keith Robison
-
Join us at the ASHG Annual Meeting from October 14th – 18th at Booth 645 to find out more about the new ‘next’ in next-generation sequencing. With...
Join us at the ASHG Annual Meeting from October 14th – 18th at Booth 645 to find out more about the new ‘next’ in next-generation sequencing. With...
Liked by Keith Robison
-
I need a new website...can you recommend someone? My Enseqlopedia site is looking a little long in the tooth and has not had a significant update...
I need a new website...can you recommend someone? My Enseqlopedia site is looking a little long in the tooth and has not had a significant update...
Liked by Keith Robison
-
#BIOEurope is around the corner. I’m bringing exciting news from Ginkgo Datapoints to Vienna, from launching our ADME profiling services to our...
#BIOEurope is around the corner. I’m bringing exciting news from Ginkgo Datapoints to Vienna, from launching our ADME profiling services to our...
Liked by Keith Robison
-
Today at #ASHG25 from the Quinlan Lab (past and present): 1. Lab alum Ryan Layer (now at CU Boulder) moderates the "Evolution of the Coding and...
Today at #ASHG25 from the Quinlan Lab (past and present): 1. Lab alum Ryan Layer (now at CU Boulder) moderates the "Evolution of the Coding and...
Liked by Keith Robison
-
Meet us at #ASHG2025 🇺🇸 & join our Industry Education Session. True Multiomics: Connecting Genotype and Transcriptome at Single-Cell Resolution 🗓️...
Meet us at #ASHG2025 🇺🇸 & join our Industry Education Session. True Multiomics: Connecting Genotype and Transcriptome at Single-Cell Resolution 🗓️...
Liked by Keith Robison
-
For years, researchers, clinicians, and life sciences companies have asked for a deeper understanding of biology. They told us that their next-level...
For years, researchers, clinicians, and life sciences companies have asked for a deeper understanding of biology. They told us that their next-level...
Liked by Keith Robison
-
Welcome to Boston, #ASHG25! We’re excited to participate in another esteemed gathering of scientists in our own backyard, and to connect with the...
Welcome to Boston, #ASHG25! We’re excited to participate in another esteemed gathering of scientists in our own backyard, and to connect with the...
Liked by Keith Robison
-
We’re here at #ASHG25 and ready to share how our latest innovations are shaping the next wave of biology. From scalable single-omic to fully...
We’re here at #ASHG25 and ready to share how our latest innovations are shaping the next wave of biology. From scalable single-omic to fully...
Liked by Keith Robison
-
IGB researchers will partner with investigators from Ginkgo Bioworks, Inc., Baylor University, University of Minnesota, Oregon State University, and...
IGB researchers will partner with investigators from Ginkgo Bioworks, Inc., Baylor University, University of Minnesota, Oregon State University, and...
Liked by Keith Robison
-
Excited for five days of inspiring science at #ASHG2025! ( American Society of Human Genetics annual meeting) Super proud of Manman Shi for receiving...
Excited for five days of inspiring science at #ASHG2025! ( American Society of Human Genetics annual meeting) Super proud of Manman Shi for receiving...
Liked by Keith Robison
View Keith’s full profile
Other similar profiles
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named Keith Robison in United States
-
Keith Robison
Seattle, WA -
Keith Robison
Senior Principal Systems Engineer | Veteran | Innovator
Tucson, AZ -
Keith Robison
Experienced Highly Skilled Business Development Professional with over 30 years of experience in the Educational Market
Greater Houston -
Keith Robison
Syracuse, NY
24 others named Keith Robison in United States are on LinkedIn
See others named Keith Robison